THROMYCIN

This brand name is authorized in Nigeria.

Active ingredients

The drug THROMYCIN contains one active pharmaceutical ingredient (API):

1	Erythromycin UNII 63937KV33D - ERYTHROMYCIN
	Erythromycin exerts its antimicrobial action by binding to the 50S ribosomal sub-unit of susceptible microorganisms and suppresses protein synthesis. Erythromycin is bacteriostatic and bactericidal depending on its concentration and the type of organism.
	Read more about Erythromycin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-0383	Ointment	Thromycin Eye Ointment OINTMENT 0.5%	Ophthalmic Ointment	20/12/2019
A11-0462	Powder for suspension	Thromycin Suspension PWD_F_SOL 125 mg/5 mL	Powder for Oral Suspension Each 5 mL reconstituted suspension contains: Erythromycin Ethyl Succinate 125 mg	07/05/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01AA17	Erythromycin	S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AA Antibiotics
Discover more medicines within S01AA17

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-0383, A11-0462